SCHEMBL16601643

SCHEMBL16601643

O=C1c2ccc3c4c(ccc(c24)C(=O)N1c1ccccc1O)C(=O)N(c1ccccc1O)C3=O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.60
KMT2A Q03164 6/20 0.60
MAPT P10636 1/20 0.60
HTT P42858 1/20 0.60
TLR9 Q9NR96 1/20 0.60
L3MBTL1 Q9Y468 1/20 0.60
POLB P06746 4/20 0.50
APAF1 O14727 1/20 0.50
ESR1 P03372 3/20 0.49
ESR2 Q92731 2/20 0.49
NPC1 O15118 2/20 0.49
RAB9A P51151 2/20 0.49
KDM4E B2RXH2 2/20 0.46
GAA P10253 1/20 0.46
DNM2 P50570 1/20 0.42
NR1H3 Q13133 1/20 0.42
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18470133 0.90 MEN1 (0.52) MEN1KMT2AMAPTHTTTLR9
SCHEMBL2150841 0.88 MEN1 (0.55) MEN1KMT2AMAPTHTTTLR9
SCHEMBL8079827 0.82 ESR1 (0.72) MEN1KMT2AMAPTHTTTLR9
SCHEMBL29009411 0.81 KMT2A (0.64) MEN1KMT2AMAPTHTTTLR9
SCHEMBL29009437 0.81 L3MBTL1 (0.64) MEN1KMT2AMAPTHTTTLR9
SCHEMBL16601654 0.80 KMT2A (0.44) MEN1KMT2AMAPTHTTTLR9
SCHEMBL9588431 0.79 ANPEP (0.58) MEN1KMT2AMAPTHTTTLR9
SCHEMBL16601670 0.79 DPP4 (0.53) MEN1KMT2AMAPTHTTTLR9
SCHEMBL16864816 0.78 MEN1 (0.48) MEN1KMT2AMAPTHTTTLR9
SCHEMBL17946433 0.78 APEX1 (0.69) MEN1KMT2AMAPTHTTTLR9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10596164-B2 Anti-clostridium compounds NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETENSCHAPPELIJK ONDERZOEK TNO (NL) 2020-03-24 US disclosed
US-20170035750-A1 NEW ANTI-CLOSTRIDIUM COMPOUNDS NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETEN SCHAPPELIJK ONDERZOEK TNO (NL) 2017-02-09 US disclosed
US-20170035750-A1 NEW ANTI-CLOSTRIDIUM COMPOUNDS NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETEN SCHAPPELIJK ONDERZOEK TNO (NL) 2017-02-09 US disclosed
US-9012112-B2 Electrophotographic photosensitive member, process cartridge, and electrophotographic apparatus CANON KABUSHIKI KAISHA (JP) 2015-04-21 US disclosed
US-9012112-B2 Electrophotographic photosensitive member, process cartridge, and electrophotographic apparatus CANON KABUSHIKI KAISHA (JP) 2015-04-21 US disclosed
US-8993205-B2 Electrophotographic photosensitive member, process cartridge, and electrophotographic apparatus CANON KABUSHIKI KAISHA (JP) 2015-03-31 US disclosed
US-8993205-B2 Electrophotographic photosensitive member, process cartridge, and electrophotographic apparatus CANON KABUSHIKI KAISHA (JP) 2015-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10596164-B2 Anti-clostridium compounds CLPP, ATP5F1A, ATP5F1C MEN1 4601/4885KMT2A 4512/4885MAPT 3960/4885
US-20170035750-A1 NEW ANTI-CLOSTRIDIUM COMPOUNDS ANTXR2, CLPP, DAD1 MEN1 4740/4885KMT2A 4578/4885MAPT 2771/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.